[Asia Economy, reporter Hyunyi Cho] GC Labcell announced on the 18th that natural killer (NK) cells have been found to be effective in treating the novel coronavirus disease (COVID-19).


GC Labcell, in collaboration with a research team from Chungbuk National University College of Medicine, confirmed through laboratory studies that cells infected with COVID-19 were eliminated by the NK cell therapy.


This study was conducted by exposing NK cells to both cells infected with the COVID-19 virus and uninfected cells, in order to verify their efficacy.


The results showed that NK cells were activated more than 7 to 8 times in virus-infected cells compared to the control group, and the secretion of interferon-gamma, which is essential for the body's immune response, increased by approximately 1.5 times compared to the control group. The company stated, "This means that NK cells induce the elimination of COVID-19-infected cells both directly and indirectly."



Hwang Youkyung, head of the Cell Therapy Research Institute at GC Labcell, said, "This study has verified not only the anti-cancer effects of NK cells, but also their antiviral efficacy," and added, "We plan to accumulate significant preclinical data through follow-up studies and pursue global clinical trials."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing